NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding NextCure, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 30 | 17 | −13 |
| SharesConverted for a 1-for-12 split | 878.9K | 858.1K | −20.8K (−2.4%) |
| Value | $5.65M | $5.03M | −$620.7K (−11.0%) |
New holders (0)
Institutions that held NextCure, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
None.
Sold out (13)
Institutions that held NextCure, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Macquarie Group Ltd | 150,000 | $69.0K |
| ADAR1 Capital Management, LLC | 118,012 | $54.3K |
| Armistice Capital, LLC | 104,000 | $47.8K |
| State Street Corp | 65,392 | $30.1K |
| Citadel Advisors LLC | 58,845 | $27.1K |
| Northern Trust Corp | 47,493 | $21.8K |
| Velan Capital Investment Management LP | 45,000 | $20.7K |
| Ieq Capital, LLC | 37,342 | $17.2K |
| Susquehanna International Group, LLP | 29,503 | $13.6K |
| HSBC Holdings PLC | 17,257 | $8.09K |
| Schonfeld Strategic Advisors LLC | 13,835 | $6.36K |
| Tower Research Capital LLC (TRC) | 1,528 | $703 |
| Simplex Trading, LLC | 920 | $0 |